Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer

Abstract

BackgroundPeritoneal recurrence is one of the most frequent recurrent diseases in gastric cancer. Although the exposure of cancer cells to the serosal surface is considered a common risk factor for peritoneal recurrence, there are some cases of peritoneal recurrence without infiltration to the serosal surface even after curative surgery. This study sought to clarify the risk factors of peritoneal recurrence in the absence of invasion to the serosal surface. Materials and methodsNinety-six patients with gastric cancer who underwent curative surgery were enrolled. In all 96 cases, the depth of tumor invasion was subserosal (T3). The microscopic distance from the tumor invasion front to the serosa (DIFS) was measured using tissue slides by H&E staining and pan-cytokeratin staining. E-cadherin expression was evaluated by immunohistochemical staining. ResultsAmong the 96 patients, 16 developed peritoneal recurrence after curative surgery. The DIFS of the tumors with peritoneal recurrence (156±220 μm) was significantly shorter (p = 0.011) than that without peritoneal recurrence (360±478 μm). Peritoneal recurrence was significantly correlated with DIFS �234 μm (p = 0.023), but not with E-cadherin expression. The prognosis of DIFS �234 μm was significantly poorer than that of DIFS >234 μm (log rank, p = 0.007). A multivariate analysis of the patients' five-year overall survival revealed PLOS ONE | https://doi.

Enhanced Intraperitoneal Delivery of Charged, Aerosolized Curcumin Nanoparticles by Electrostatic Precipitation

“…The enhanced depth of tissue penetration of positively charged NPs after ePIPAC delivery may be clinically relevant. The tumor invasion front is located approximately 150 μm below the tumor rim in patients developing peritoneal future science group www.futuremedicine.com metastasis, whereas this front is deeper in patients without peritoneal recurrence (>300 μm) [32]. The evaluation of the clinical significance of these results will require further investigation, but it is evident that intraperitoneal drug delivery to the target tissue can be optimized by a combination of medical devices, formulation of the drug and control of the peritoneal environment.…”

The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients

“…Since most of gastric cancer cells frequently produce TGFβ [ 21 ], TGFβ from gastric cancer cells might activate Tks5 the PMCs via TGFβ-Src-Tks5 signaling. It is conceivable that peritoneal metastasis develops through direct invasion of cancer cells into the gastric wall, exfoliation of free cancer cells from the tumor to the peritoneal cavity, and adhesion to the peritoneum [ 22 , 23 ]. On the other hand, the clinical relevance of Tks5 in PMCs has not been clarified.…”

Prognostic value of preoperative glucose to lymphocytes ratio in patients with resected gastric cancer

“…Our results showed that mortality was significantly higher in the patient group with lymphovascular or serosal invasion. Previous studies have shown that gastric cancer patients with serosal invasion have a higher rate of peritoneal involvement and need neoadjuvant chemoradiotherapy [20][21][22].…”